Infoscan wants to move to WSE main market

Listed on the small-cap, alternative NewConnect market, telemedicine and remote diagnostics devices producer Infoscan, will decide on June 28 whether to move company’s stock to the WSE main market, the company said in a market filing. The company hopes that the switch will occur in Q1 next year and do not plan to issue new shares because of it. “The decision to move to the main market is a consequence of our previous announcements, but also the company's development, Infoscan, diversifying its geographical and production activities in the last dozen or so months, has significantly increased its value. grew further along with the implementation of milestones. Another such will be obtaining the FDA certification for the US market for the MED Recorder device, which we expect in the near future,” said the company’s President Jacek Gnich.